Original article
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
Seguridad de los anticuerpos monoclonales anti-CGRP en pacientes con migraña durante la pandemia de COVID-19: implicaciones actuales y futuras
E. Caronnaa,b, V. José Gallardob, A. Alpuentea,b, M. Torres-Ferrusa,b, N.M. Sánchez-Mateoc, J. Viguera-Romerod, A.C. López-Velosoe, A. López-Bravof, A.B. Gago-Veigag, P. Irimia Sieirah, J. Porta-Etessami, S. Santos-Lasaosaj, P. Pozo-Rosicha,b,
, Spanish CGRP-COVID Study Group
Corresponding author
a Headache Unit, Neurology Department, Hospital Universitari Vall d’Hebron, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
b Headache and Neurological Pain Research Group, Vall d’Hebron Research Institute, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
c Headache Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
d Headache Unit, Neuroscience Department, Hospital Universitario Virgen Macarena, Sevilla, Spain
e Neurology Department, Hospital Universitario de Gran Canaria Dr. Negrín, Gran Canaria, Spain
f Neurology Department, Hospital Reina Sofia, Tudela, Spain
g Headache Unit, Neurology Department, Hospital Universitario de La Princesa & Instituto de Investigación Sanitaria de La Princesa, Madrid, Spain
h Neurology Department, Clinica Universidad de Navarra, Pamplona, Spain
i Department of Neurology, Institute of Neurosciences, Hospital Clínico San Carlos, IdISSC, Universidad Complutense de Madrid, Madrid, Spain
j Headache Unit, Neurology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
Ver másRead
2853
Timeswas read the article
590
Total PDF
2263
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 13 | 15 | 28 |
| 2025 11 | 47 | 52 | 99 |
| 2025 10 | 54 | 18 | 72 |
| 2025 9 | 42 | 25 | 67 |
| 2025 8 | 38 | 26 | 64 |
| 2025 7 | 53 | 17 | 70 |
| 2025 6 | 52 | 8 | 60 |
| 2025 5 | 50 | 11 | 61 |
| 2025 4 | 31 | 4 | 35 |
| 2025 3 | 55 | 7 | 62 |
| 2025 2 | 41 | 9 | 50 |
| 2025 1 | 86 | 22 | 108 |
| 2024 12 | 35 | 1 | 36 |
| 2024 11 | 26 | 8 | 34 |
| 2024 10 | 16 | 12 | 28 |
| 2024 9 | 42 | 2 | 44 |
| 2024 8 | 34 | 3 | 37 |
| 2024 7 | 53 | 3 | 56 |
| 2024 6 | 38 | 3 | 41 |
| 2024 5 | 25 | 4 | 29 |
| 2024 4 | 26 | 10 | 36 |
| 2024 3 | 76 | 3 | 79 |
| 2024 2 | 53 | 11 | 64 |
| 2024 1 | 24 | 5 | 29 |
| 2023 12 | 39 | 12 | 51 |
| 2023 11 | 48 | 3 | 51 |
| 2023 10 | 54 | 11 | 65 |
| 2023 9 | 38 | 5 | 43 |
| 2023 8 | 19 | 9 | 28 |
| 2023 7 | 15 | 7 | 22 |
| 2023 6 | 29 | 3 | 32 |
| 2023 5 | 20 | 1 | 21 |
| 2023 4 | 33 | 8 | 41 |
| 2023 3 | 26 | 5 | 31 |
| 2023 2 | 21 | 0 | 21 |
| 2023 1 | 19 | 10 | 29 |
| 2022 12 | 60 | 3 | 63 |
| 2022 11 | 35 | 10 | 45 |
| 2022 10 | 34 | 9 | 43 |
| 2022 9 | 32 | 8 | 40 |
| 2022 8 | 35 | 12 | 47 |
| 2022 7 | 30 | 6 | 36 |
| 2022 6 | 43 | 19 | 62 |
| 2022 5 | 49 | 17 | 66 |
| 2022 4 | 74 | 20 | 94 |
| 2022 3 | 94 | 31 | 125 |
| 2022 2 | 69 | 15 | 84 |
| 2022 1 | 129 | 18 | 147 |
| 2021 12 | 68 | 26 | 94 |
| 2021 11 | 83 | 26 | 109 |
| 2021 10 | 57 | 17 | 74 |
Show all
